We report on the effect of lung-density correction on dose distribution in a transverse slice containing the isocenter for tangential-fields breast irradiation. In this case study we analyzed the target coverage as well as hot spots for four types of treatment plans: Plan 1 assumes uniform unit density throughout, Plan 2 utilizes all the treatment parameters of Plan 1, but takes into account the lower lung density. Plan 3 is generated by optimizing the dose distribution in the presence of the lower lung density, and Plan 4 is an improvement on Plan 3 by using custom instead of standard wedges. Our analysis shows that consideration of the lower lung density is important for optimal treatment planning for the breast and that specially designed wedges can improve the dose distribution.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0958-3947(89)90180-5DOI Listing

Publication Analysis

Top Keywords

dose distribution
12
density plan
12
lower lung
12
lung density
12
lung-density correction
8
treatment planning
8
tangential-fields breast
8
breast irradiation
8
irradiation case
8
plan
6

Similar Publications

Long-term use of low-dose aspirin has been demonstrated to reduce cancer risk, but the duration of necessary medication use remains uncertain. This study aimed to investigate the long-term chemoprotective effect of aspirin among the Chinese population. This population-based study included all aspirin users between 2000 and 2019.

View Article and Find Full Text PDF

Multi-layer shielding optimization of a high activity Am-Be mixed field irradiation facility.

Appl Radiat Isot

January 2025

Experimental Nuclear Physics Department, Nuclear Research Centre, Egyptian Atomic Energy Authority, Egypt; Cyclotron Facility, Egyptian Atomic Energy Authority, Egypt.

Neutron and gamma-ray shielding design for a 30Ci (1.11TBq) Am-Be irradiation facility is studied using MCNP5 Monte Carlo simulation code. The study focuses on the optimization of the shielding layers of the previously planned neutron irradiation facility.

View Article and Find Full Text PDF

Bangladesh completed a primary series of COVID-19 vaccinations for about 86 individuals per 100 population as of 5 July 2023. However, ensuring higher coverage in vulnerable areas is challenging. We report on the COVID-19 vaccine uptake and associated factors among adults in two vulnerable areas in Bangladesh.

View Article and Find Full Text PDF

Determinants of COVID-19 vaccination coverage in European and Organisation for Economic Co-operation and Development (OECD) countries.

Front Public Health

January 2025

Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.

Introduction: In relatively wealthy countries, substantial between-country variability in COVID-19 vaccination coverage occurred. We aimed to identify influential national-level determinants of COVID-19 vaccine uptake at different COVID-19 pandemic stages in such countries.

Methods: We considered over 50 macro-level demographic, healthcare resource, disease burden, political, socio-economic, labor, cultural, life-style indicators as explanatory factors and coverage with at least one dose by June 2021, completed initial vaccination protocols by December 2021, and booster doses by June 2022 as outcomes.

View Article and Find Full Text PDF

Background: 7-Hydroxymethotrexate (7-OHMTX) is the main metabolite in plasma following high-dose MTX (HD-MTX), which may result in activity and toxicity of the MTX. Moreover, 7-OHMTX could produce crystalline-like deposits within the renal tubules under acidic conditions or induce renal inflammation, oxidative stress, and cell apoptosis through various signaling pathways, ultimately leading to kidney damage. The objectives of this study were thus to explore the exposure-safety relationship of two compounds and search the most reliable marker for predicting HDMTX nephrotoxicity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!